Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-08-26
1999-05-04
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514221, 514300, 514303, A61K 31495, A61K 3150
Patent
active
059004142
ABSTRACT:
The compositions and methods of the invention provide a convenient means for systemically administering an integrin receptor antagonist or a pharmaceutically effective amount thereof to a patient by introducing the antagonist, in an ophthalmic formulation, to the patient's eye.
REFERENCES:
patent: 5229366 (1993-07-01), Tsukada et al.
patent: 5281585 (1994-01-01), Duggan et al.
patent: 5292756 (1994-03-01), Duggan et al.
patent: 5470849 (1995-11-01), Callahan et al.
Dahlof et al., Allergy, 42 (3), 215-21, Apr. 1987.
Keenan et al., -Book of Abstract, 211.sup.th National Meeting, mar. 24-28 (1996), Medi.-236 ACS code:62PIAJ.
Gould Robert J.
Hartman George D.
Sugrue Michael F.
Henley III Raymond
Merck & Co. , Inc.
Moezie M.
Parr Richard S.
Winokur Melvin
LandOfFree
Methods for administering integrin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for administering integrin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for administering integrin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1869643